Behcet's Disease (A Study of 23 Cases From Tripoli, Libya)

Area of Science:

• Rheumatology
• Immunology
• Dermatology

Background:

• Behcet's disease is a rare multisystemic inflammatory disorder.
• Understanding its clinical manifestations and treatment responses is crucial for patient management.

Purpose of the Study:

• To describe the clinical characteristics of Behcet's disease in a cohort of 23 patients.
• To evaluate the efficacy of different treatment modalities.

Main Methods:

• Retrospective analysis of 23 patients diagnosed with Behcet's disease.
• Clinical data collection including demographics, symptoms, and treatment outcomes.
• Erythrocyte sedimentation rate (ESR) monitoring during active disease phases.

Main Results:

• Male predominance (82.6%) with onset typically between 21-30 years (70%).
• Recurrent oral and genital ulcers were universal; other common involvements included eye (10), joint (6), and thrombophlebitis (4).
• Oral prednisolone controlled manifestations in 15 patients; colchicine improved oro-genital and skin lesions in 7.

Conclusions:

• Behcet's disease presents with characteristic mucocutaneous lesions and can affect multiple organ systems.
• Corticosteroids, particularly oral prednisolone, are effective in managing disease activity.
• Combination therapy may be beneficial for severe cases, though visual prognosis can be guarded.